|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dawsey SP, Tonui S, Parker RK, Fitzwater
JW, Dawsey SM, White RE and Abnet CC: Esophageal cancer in young
people: A case series of 109 cases and review of the literature.
PLoS One. 5:e140802010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang HY, Spechler SJ and Souza RF:
Esophageal adenocarcinoma arising in Barrett esophagus. Cancer
Lett. 275:170–177. 2009. View Article : Google Scholar :
|
|
4
|
Hong J, Peng D, Chen Z, Sehdev V and
Belkhiri A: ABL regulation by AXL promotes cisplatin resistance in
esophageal cancer. Cancer Res. 73:331–340. 2013. View Article : Google Scholar
|
|
5
|
Grünberger B, Raderer M, Schmidinger M and
Hejna M: Palliative chemotherapy for recurrent and metastatic
esophageal cancer. Anticancer Res. 27(4C): 2705–2714.
2007.PubMed/NCBI
|
|
6
|
Lin C, Song L, Gong H, Liu A, Lin X, Wu J,
Li M and Li J: Nkx2-8 downregulation promotes angiogenesis and
activates NF-κB in esophageal cancer. Cancer Res. 73:3638–3648.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noel A, Maillard C, Rocks N, Jost M,
Chabottaux V, Sounni NE, Maquoi E, Cataldo D and Foidart JM:
Membrane associated proteases and their inhibitors in tumour
angiogenesis. J Clin Pathol. 57:577–584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Borgoño CA and Diamandis EP: The emerging
roles of human tissue kallikreins in cancer. Nat Rev Cancer.
4:876–890. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lawrence MG, Lai J and Clements JA:
Kallikreins on steroids: Structure, function, and hormonal
regulation of prostate-specific antigen and the extended kallikrein
locus. Endocr Rev. 31:407–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo LY, Grass L, Howarth DJ, Thibault P,
Ong H and Diamandis EP: Immunofluorometric assay of human
kallikrein 10 and its identification in biological fluids and
tissues. Clin Chem. 47:237–246. 2001.PubMed/NCBI
|
|
11
|
Talieri M, Alexopoulou DK, Scorilas A,
Kypraios D, Arnogiannaki N, Devetzi M, Patsavela M and Xynopoulos
D: Expression analysis and clinical evaluation of
kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Tumour Biol. 32:737–744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Michael IP, Kurlender L, Memari N, Yousef
GM, Du D, Grass L, Stephan C, Jung K and Diamandis EP: Intron
retention: A common splicing event within the human kallikrein gene
family. Clin Chem. 51:506–515. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu XL, Wazer DE, Watanabe K and Band V:
Identification of a novel serine protease-like gene, the expression
of which is down-regulated during breast cancer progression. Cancer
Res. 56:3371–3379. 1996.PubMed/NCBI
|
|
14
|
Sidiropoulos M, Pampalakis G, Sotiropoulou
G, Katsaros D and Diamandis EP: Downregulation of human kallikrein
10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian
and prostate cancers. Tumour Biol. 26:324–336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Song H, Miao Y, Wang R and Chen
L: Frequent transcriptional inactivation of kallikrein 10 gene by
CpG island hypermethylation in non-small cell lung cancer. Cancer
Sci. 101:934–940. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
White NM, Bui A, Mejia-Guerrero S, Chao J,
Soosaipillai A, Youssef Y, Mankaruos M, Honey RJ, Stewart R, Pace
KT, et al: Dysregulation of kallikrein-related peptidases in renal
cell carcinoma: Potential targets of miRNAs. Biol Chem.
391:411–423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Treeck O, Schüler S, Häring J, Skrzypczak
M, Lattrich C and Ortmann O: icb-1 gene counteracts growth of
ovarian cancer cell lines. Cancer Lett. 335:441–446. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Santin AD, Diamandis EP, Bellone S,
Marizzoni M, Bandiera E, Palmieri M, Papasakelariou C, Katsaros D,
Burnett A and Pecorelli S: Overexpression of kallikrein 10 (hK10)
in uterine serous papillary carcinomas. Am J Obstet Gynecol.
194:1296–1302. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rückert F, Hennig M, Petraki CD, Wehrum D,
Distler M, Denz A, Schröder M, Dawelbait G, Kalthoff H, Saeger HD,
et al: Co-expression of KLK6 and KLK10 as prognostic factors for
survival in pancreatic ductal adenocarcinoma. Br J Cancer.
99:1484–1492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YY, Lin YC, Hung HC, Tien WY and
Shieh TY: Polymorphisms in kallikrein7 and 10 genes and oral cancer
risks in Taiwan betel quid chewers and smokers. Oral Dis.
19:824–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pettus JR, Johnson JJ, Shi Z, Davis JW,
Koblinski J, Ghosh S, Liu Y, Ravosa MJ, Frazier S and Stack MS:
Multiple kallikrein (KLK 5,7,8, and 10) expression in squamous cell
carcinoma of the oral cavity. Histol Histopathol. 24:197–207.
2009.
|
|
22
|
Luo LY, Grass L and Diamandis EP: Steroid
hormone regulation of the human kallikrein 10 (KLK10) gene in
cancer cell lines and functional characterization of the KLK10 gene
promoter. Clin Chim Acta. 337:115–126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li B, Goyal J, Dhar S, Dimri G, Evron E,
Sukumar S, Wazer DE and Band V: CpG methylation as a basis for
breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer
Res. 61:8014–8021. 2001.PubMed/NCBI
|
|
24
|
Bin L, Kim BE, Hall CF, Leach SM and Leung
DY: Inhibition of transcription factor specificity protein 1 alters
the gene expression profile of keratinocytes leading to
upregulation of kallikrein-related peptidases and thymic stromal
lymphopoietin. J Invest Dermatol. 131:2213–2222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hao XP, Pretlow TG, Rao JS and Pretlow TP:
Beta-catenin expression is altered in human colonic aberrant crypt
foci. Cancer Res. 61:8085–8088. 2001.PubMed/NCBI
|
|
26
|
Ling S, Feng T, Ke Q, Fan N, Li L, Li Z,
Dong C, Wang C, Xu F, Li Y, et al: Metformin inhibits proliferation
and enhances chemosensitivity of intrahepatic cholangiocarcinoma
cell lines. Oncol Rep. 31:2611–2618. 2014.PubMed/NCBI
|
|
27
|
Li X, Suo J, Shao S, Xue L, Chen W, Dong
L, Shi J, Fu M, Lu N, Zhan Q, et al: Overexpression of OLC1
promotes tumorigenesis of human esophageal squamous cell carcinoma.
PLoS One. 9:e909582014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
White NM, Chow TF, Mejia-Guerrero S,
Diamandis M, Rofael Y, Faragalla H, Mankaruous M, Gabril M, Girgis
A and Yousef GM: Three dysregulated miRNAs control kallikrein 10
expression and cell proliferation in ovarian cancer. Br J Cancer.
102:1244–1253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiao X, Lu HJ, Zhai MM, Tan ZJ, Zhi HN,
Liu XM, Liu CH and Zhang DP: Overexpression of kallikrein gene 10
is a biomarker for predicting poor prognosis in gastric cancer.
World J Gastroenterol. 19:9425–9431. 2013. View Article : Google Scholar
|
|
30
|
Kolin DL, Sy K, Rotondo F, Bassily MN,
Kovacs K, Brezden-Masley C, Streutker CJ and Yousef GM: Prognostic
significance of human tissue kallikrein-related peptidases 6 and 10
in gastric cancer. Biol Chem. 395:1087–1093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Alexopoulou DK, Papadopoulos IN and
Scorilas A: Clinical significance of kallikrein-related peptidase
(KLK10) mRNA expression in colorectal cancer. Clin Biochem.
46:1453–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang BY, Goan YG, Hsu PK, Hsu WH and Wu
YC: Tumor length as a prognostic factor in esophageal squamous cell
carcinoma. Ann Thorac Surg. 91:887–893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang BY, Liu CY, Lin CH, Hsu PK, Hsu WH,
Wu YC and Cheng CY: Endoscopic tumor length is an independent
prognostic factor in esophageal squamous cell carcinoma. Ann Surg
Oncol. 19:2149–2158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Eastman A: Cell cycle checkpoints and
their impact on anticancer therapeutic strategies. J Cell Biochem.
91:223–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
